5 Results
Guidelines and Advice
Status: Current
ID: GL 1-22-A
Version: 2
ID: GL 1-22-A
Version: 2
Jul 2022
Drug
Jan 2022
Cancer facts
Guidelines and Advice
Status: Current
ID: GL 2-33
ID: GL 2-33
Jun 2022